Related references
Note: Only part of the references are listed.3D organoids derived from the small intestine: An emerging tool for drug transport research
Yuanjin Zhang et al.
ACTA PHARMACEUTICA SINICA B (2021)
Clinical Controversy in Transplantation: Tacrolimus Versus Cyclosporine in Statin Drug Interactions
Daniel R. Migliozzi et al.
ANNALS OF PHARMACOTHERAPY (2020)
Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression
Brandy Garzel et al.
PHARMACEUTICAL RESEARCH (2020)
Assessment of Pharmacokinetic Drug-Drug Interactions in Humans: In Vivo Probe Substrates for Drug Metabolism and Drug Transport Revisited
Uwe Fuhr et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
A Clinical Drug-Drug Interaction Study Assessing a Novel Drug Transporter Phenotyping Cocktail With Adefovir, Sitagliptin, Metformin, Pitavastatin, and Digoxin
Christina Trueck et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
How Transporters Have Changed Basic Pharmacokinetic Understanding
Leslie Z. Benet et al.
AAPS JOURNAL (2019)
Metformin and AMP Kinase Activation Increase Expression of the Sterol Transporters ABCG5/8 (ATP-Binding Cassette Transporter G5/G8) With Potential Antiatherogenic Consequences
Matthew M. Molusky et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium
Sook Wah Yee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance
Maciej J. Zamek-Gliszczynski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective
J. Gerry Kenna et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Evaluation of transporters in drug development: Current status and contemporary issues
Sue-Chih Lee et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
A novel mode of operation of SLC22A11: Membrane insertion of estrone sulfate versus translocation of uric acid and glutamate
Peter Skwara et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake
M. Masud Parvez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin
P. Stopfer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical SettingProposal of a Four Component Transporter Cocktail
Thomas Ebner et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates
Kristina Hacker et al.
PLOS ONE (2015)
Investigation of the Impact of Substrate Selection on In Vitro Organic Anion Transporting Polypeptide 1B1 Inhibition Profiles for the Prediction of Drug-Drug Interactions
Saki Izumi et al.
DRUG METABOLISM AND DISPOSITION (2015)
Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers
Sung Kweon Cho et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Drug interactions with statins
Anida Causevic-Ramosevac et al.
ACTA PHARMACEUTICA (2013)
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
Joerg Koenig et al.
PHARMACOLOGICAL REVIEWS (2013)
Expression of Organic Anion Transporter 2 in the Human Kidney and Its Potential Role in the Tubular Secretion of Guanine-Containing Antiviral Drugs
Yaofeng Cheng et al.
DRUG METABOLISM AND DISPOSITION (2012)
Molecular Mechanism of Renal Tubular Secretion of the Antimalarial Drug Chloroquine
Fabian Mueller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In vitro risk assessment of AZD9056 perpetrating a transporter-mediated drug-drug interaction with methotrexate
Robert Elsby et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Profiling of a Prescription Drug Library for Potential Renal Drug-Drug Interactions Mediated by the Organic Cation Transporter 2
Yasuto Kido et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Interaction of H+ with the extracellular and intracellular aspects of hMATE1
Yodying Dangprapai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Transport of Aminopterin by Human Organic Anion Transporters hOAT1 and hOAT3: Comparison with Methotrexate
Yuichi Uwai et al.
DRUG METABOLISM AND PHARMACOKINETICS (2010)
Measurement of Bile Salt Export Pump Transport Activities using a Fluorescent Bile Acid Derivative
Kana Yamaguchi et al.
DRUG METABOLISM AND PHARMACOKINETICS (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin
Ligong Chen et al.
PHARMACOGENETICS AND GENOMICS (2010)
Sitagliptin attenuates metformin-mediated AMPK phosphorylation through inhibition of organic cation transporters
Min-Koo Choi et al.
XENOBIOTICA (2010)
Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms
Henriette E. Meyer Zu Schwabedissen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
A Comparison of Uptake of Metformin and Phenformin Mediated by hOCT1 in Human Hepatocytes
Yoshihisa Sogame et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2009)
Interaction of beta-blockers with the renal uptake transporter OCT2
I. Bachmakov et al.
DIABETES OBESITY & METABOLISM (2009)
Effect of Membrane Cholesterol on BSEP/Bsep Activity: Species Specificity Studies for Substrates and Inhibitors
Emese Kis et al.
DRUG METABOLISM AND DISPOSITION (2009)
Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)
Oliver Zolk et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin
I. S. Song et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes
I. S. Song et al.
XENOBIOTICA (2008)
Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics
Y. Shu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effects of tetraalkylammonium compounds with different affinities for organic cation transporters on the pharmacokinetics of metformin
Min-Koo Choi et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2007)
Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H+-organic cation antiporters
Yuko Tanihara et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein
Xiao-Yan Chu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Fast set-up of doxycycline-inducible protein expression in human cell lines with a single plasmid based on Epstein-Barr virus replication and the simple tetracycline repressor
Markus Bach et al.
FEBS JOURNAL (2007)
Functional involvement of organic cation transporter1 (OCT1/Oct1) in the hepatic uptake of organic cations in humans and rats
K.-I. Umehara et al.
XENOBIOTICA (2007)
Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2
Satohiro Masuda et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1
H Ueo et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Pitavastatin
RYA Mukhtar et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2005)
Metformin transport by renal basolateral organic cation transporter hOCT2
N Kimura et al.
PHARMACEUTICAL RESEARCH (2005)
Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine
S Khamdang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression
M Hedman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney
Y Urakami et al.
PHARMACEUTICAL RESEARCH (2004)
Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A)
H Motohashi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Urate transport via human PAH transporter hOAT1 and its gene structure
K Ichida et al.
KIDNEY INTERNATIONAL (2003)
The human bile salt export pump: Characterization of substrate specificity and identification of inhibitors
JA Byrne et al.
GASTROENTEROLOGY (2002)
Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake
M Motojima et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Overview: ABC transporters and human disease
MM Gottesman et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2001)
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney
SH Cha et al.
MOLECULAR PHARMACOLOGY (2001)
Characterization of the mouse bile salt export pump overexpressed in the baculovirus system
J Noe et al.
HEPATOLOGY (2001)
Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1
T Cihlar et al.
ANALYTICAL BIOCHEMISTRY (2000)
Share Paper
